Directory · US
Biotechnology in United States
A register of firms and the professionals working at them in the Biotechnology sector based in United States. Browse the public index, then filter or export on Kipplo.
Companies
2.7K on file
Entegrion, Inc
Entegrion identifies, invents and systematically develops device and biological technologies to meet clearly defined medical needs. Our pipeline is distinguished by its uniqueness- we pursue areas with limited competition and profound needs. We design efficient and focused development plans to assure that the products we deliver perform as intended and are ready for market. Twitter @entegrioninfo
1 to 10 staff
Gator Bio
Gator Bio delivers the reproducibility and reliability that life sciences labs depend on for biomolecular research and development. Validated across 400+ installations, our platform provides: • <5% CV reproducibility—consistent kinetics from discovery through regulatory submissions • 30+ biosensor options for antibodies, proteins, and small molecules • 20 regeneration cycles for low cost of operation • PhD-level application support from scientists who understand your assays Modern BLI technology with better total economics that solves the performance and reliability challenges of legacy platforms.
51 to 200 staff
Graphite Bio
Graphite Bio is a clinical-stage, next-generation gene editing company driven to discover and develop cures for a wide range of serious and life-threatening diseases. The company is pioneering a precision gene editing approach that has the potential to transform human health by achieving one of medicine’s most elusive goals: to precisely “find & replace” any gene in the genome. Graphite Bio’s UltraHDR™ gene editing platform takes CRISPR beyond cutting and harnesses the power of high-efficiency precision DNA repair, also known as homology-directed repair (HDR), to precisely correct genetic mutations, replace entire disease-causing genes with functional genes or insert new genes into predetermined, safe locations. Additionally, the company is advancing the development of novel conditioning regimens to help bring curative therapies to more patients. The company was co-founded by academic pioneers in the fields of gene editing and gene therapy, including Maria Grazia Roncarolo, M.D, and Matthew Porteus, M.D, Ph.D. See our Community Guidelines at bit.ly/3c5Pztz.
51 to 200 staff
Hy-Line International
Global market leader in development and marketing of egg layer genetic stock. Founded in 1936 by Henry A. Wallace, Hy-Line International was the first poultry breeding company to apply the principles of hybridization to commercial layer breeding. Today, Hy-Line International continues to be a pioneer as the first company with its own in-house molecular genetics team leading the industry in application of DNA-based technology to its breeding and genetics program. Hy-Line produces and sells brown, tint and white egg stock to more than 120 countries worldwide and is the largest selling layer in the American egg industry and around the world.
201 to 500 staff
Indupro
InduPro is bringing life-changing therapies to patients through novel cell-surface platform technologies. We are defining and manipulating protein interactions beyond natural signaling paradigms. InduPro platforms, integrate inherent protein proximity at the cell surface with the ability to manipulate protein pairings via induced protein proximity to create novel signaling pathways and logic gates.
11 to 50 staff
Isurtec
Innovative Surface Technologies (ISurTec) develops and provides surface transformation technologies engineered to solve difficult challenges in the biotech and medical device fields. Founded in 2004, we first released a high-performance lubricious hydrophilic coating designed for medical devices. This technology is used worldwide by many of the major medical devices companies in the field today under the ISurGlide and Lubricent brand names. We continue to develop innovative coatings to highlight other surface properties. We’re currently developing next generation hydrophilic coatings that lower provider’s coating costs, improve lubricity, and lower particulate while also developing surfaces that resist protein adhesion for use in biotech/biopharm R&D. If you have a difficult surface transformation problem contact us!
11 to 50 staff
Lifemine Therapeutics
LifeMine Therapeutics is a clinical-stage biopharmaceutical company pioneering Top-Down Drug DiscoveryTM, which leverages evolutionary insights from fungi to unearth next-generation precision medicines. LifeMine’s data-immersive platform integrates the latest advancements in human genetics and genomics, bioinformatics, machine learning and synthetic biology. LifeMine’s lead program, LIFE-001, is a novel, precision-engineered, long-acting calcineurin inhibitor being developed for multiple immunologic disorders and organ transplantation.
51 to 200 staff
Medical Education & Research Institute
The MERI is a nonprofit medical teaching and training facility in Memphis, Tennessee qualified under section 501 (c)(3) of the Internal Revenue Code. The MERI conducts state-of-the-art, hands-on educational courses for physicians, nurses and other medical professionals from across the country and around the world. At the MERI, medical professionals are introduced to the latest innovations in medicine, and have the opportunity to learn first-hand about the most up-to-date medical techniques and technologies. The MERI supports research in all specialties by providing the sponsor with the most effective environment for achieving maximal outcomes for their studies.
11 to 50 staff
Medtomarket, Inc
Located in the St. Elmo District in South Austin, TX our new square state-of-the-art medical innovation and education center focuses on pushes the boundaries of traditional medical training with 36 bioskills labs stations, the M2M Robotics Center of Excellence, M2M Events, and an extensive network of physicians and nurses.
1 to 10 staff
Midsci
MIDSCI is a customer focused laboratory equipment and supply provider. Our products are geared towards improving consistency and reproducibility. We primarily focus on cell/tissue culture, PCR, liquid handling, westerns, centrifugation, incubation, cold storage, and all other processes performed in molecular biology labs. Visit us at Email us at custserv@midsci.com Call us at Still fax, we gotcha at FB facebook.com/Midsci/
11 to 50 staff
Neurogene Inc
Neurogene is accelerating development of new genetic medicines to people with devastating neurological diseases and their families. To do this, we are working with experts across the globe to advance a broad pipeline of programs to treat the underlying cause of serious neurological disorders and thereby address the overwhelming need for new therapies. Although the human genome was sequenced for the first time nearly 20 years ago, the true genomics revolution is taking place now, providing us with the ability to radically alter rare, genetic disorders. At Neurogene, we are working to provide medicines to improve the lives of neurologically-impaired and developmentally-delayed children and their families. We are building a team of passionate, driven individuals who envision a world in which all families have access to genetic medicines, even if the disorder is exceedingly rare. To learn more, please visit
51 to 200 staff
One Codex
One Codex is the leading bioinformatics platform for microbial genomics, supporting taxonomic and functional analysis of metagenomic (WGS), 16S, and other sequencing data. We specialize in creating robust, scalable, and secure bioinformatics solutions for metagenomics and microbial genomics, with a strong focus on ease of use. Founded in 2014, the One Codex platform counts thousands of users across leading academic institutions, biotechnology companies, and public sector organizations. One Codex is built on top of Amazon Web Services and is the only microbial genomics offering providing HIPAA-level security, as well as other strong compliance and audit guarantees. To learn more, visit
11 to 50 staff
Pds Biotechnology
PDS Biotech is a clinical-stage biopharmaceutical company focused on the development and commercialization of T-cell Stimulating Immunotherapies (TSI) based on the Versamune® platform, designed to harness the power of the body's immune system in the fight against cancer.
11 to 50 staff
Phi Life Sciences
Phi Life Sciences is a Molecular Diagnostic and Laboratory Service company that aims to help patients by reducing disease mortality and adverse drug reactions through affordable, state of the art screening and diagnostic technologies. Phi Life Sciences is the bridge between scientists with innovative technologies and the patients and doctors whom they can benefit. We build this bridge through products developed in laboratory services and offered to patients and doctors through clinical services. Phi Life sciences aims to improve the efficiency, delivery, accessibility, and utility of molecular testing services through innovative technologies, licensed products, and clinically actionable result that empower physicians to deliver precision treatments and diagnoses by incorporating molecular tests that will improve their patients’ health. Phi Life Sciences aims to improve patient health through the use of cutting edge molecular diagnostic tools. We exist to achieve the human potential.
1 to 10 staff
Pooprints
PooPrints, a product of BioPet Laboratories, is the DNA dog waste management company offering a solution to pet pollution in communities across the U.S, Mexico, Canada and the United Kingdom. It isn’t just a problem in your community — it’s everywhere. As the first and largest commercial DNA Waste Management Program, PooPrints eliminates 96% of waste within 60 days of launch. Our goal is to increase responsible pet ownership through education, expand pet access and decrease the environmental impact of dog waste.
11 to 50 staff
Pyc Therapeutics Asx Pyc
PYC Therapeutics (ASX: PYC) is a clinical stage biotechnology company pioneering a new generation of RNA therapeutics for genetic diseases. It works by combining two complementary platforms: RNA-based drug design and PYC’s proprietary drug delivery technology. PYC's library of naturally derived cell penetrating peptides provide its delivery platform to overcome the major challenges of RNA therapeutics - getting into the target cell. PYC believes its PPMO (Peptide conjugated Phosphorodiamidate Morpholino Oligomer) technology enables a safer and more effective RNA therapeutic to address the underlying drivers of a range of genetic diseases for which no treatment solutions exist today. The Company is leveraging its leading-edge science to develop a pipeline of novel therapies including two programs focused on inherited eye diseases and preclinical discovery efforts focused on neurodegenerative diseases. PYC’s discovery and laboratory operations are located in Australia, and the Company’s preclinical and clinical operations are based in San Fransisco California.
51 to 200 staff
Q Bio
We are a team of engineers, scientists and doctors working at the intersection of AI, Physics and Biology to make the Star Trek MedBay a reality.
51 to 200 staff
Quantgene
Quantgene decentralizes genomics to bring precision medicine to everyone. Our turnkey genomics platform empowers hospitals to move life-saving genomic diagnostics inside their organizations, unlock powerful new sources of revenue and become a driving force in clinical discovery. From complete genomic profiling to hereditary cancer testing and multi-cancer early detection, we help hospitals, physicians and patients to unlock the full power of precision genomics.
11 to 50 staff
Siga Technologies
SIGA is a leader in global health, developing medicines to prevent and treat emerging infectious diseases with high unmet medical needs. Infectious diseases pose an imminent and severe threat to global health that cannot be adequately addressed with vaccines alone. Smallpox, mpox, and other orthopoxviruses are particularly worrisome because they are highly infectious and deadly. We are developing best-in-class products to treat these infections in patients worldwide.
51 to 200 staff
Simbiosys
SimBioSys is a pioneering TechBio company leveraging artificial intelligence and biophysical modeling to harness the power of spatial biophysics to redefine precision medicine, transform patient care and defeat cancer. By seeing cancer more completely, SimBioSys aims to empower clinicians and researchers with a more informed understanding of a patient’s tumor to optimally assess all available options and deliver on the promise of truly individualized patient care. To learn more, visit us at
11 to 50 staff
Solarbiotech
Solar Biotech is a technology and bioproducts development start-up that utilizes biological systems and cutting-edge biomanufacturing technologies to develop and produce SynBio products through precision fermentation and state-of-the-art downstream processing technologies. Not a solar power company. The goal of the company is to become a global leader, provider of sustainable, microbial cell-based biomanufacturing technologies and services across different SynBio market segments, including the SynBio FoodTech segment. Recognising rising consumer trends for sustainable, traceable, healthier, and safer consumer products, Solar Biotech is committed to operating sustainably and to delivering the highest quality SynBio products available to clients worldwide.
11 to 50 staff
Stealth Biotherapeutics
Our Mission Stealth BioTherapeutics is an innovative biopharmaceutical company developing therapies to treat mitochondrial dysfunction associated with genetic mitochondrial diseases and common diseases of aging. Our team works with patients and advocacy organizations to better understand their journey and raise awareness of the unmet need our programs seek to address. We collaborate with top-tier academic and medical institutions, scientific thought leaders, and clinical key opinion leaders in developing the first generation of targeted therapies focusing on mitochondrial dysfunction as it presents in these rare genetic diseases and common diseases of aging. With these collaborative efforts, we continue to advance our platform of late-stage clinical programs and novel pipeline candidates. Please be aware of the potential for scams claiming to represent Stealth BioTherapeutics in recruitment activities. Stealth exclusively uses @stealthbt.com e-mail addresses for recruitment purposes and does not conduct interviews via social media or other third-party sites. Please report any suspicious recruiting activity to us at careers@stealthbt.com and to the Internet Crime Complaint Center.
51 to 200 staff
Surrozen
Surrozen is a biotechnology company focused on discovering and developing novel regenerative medicines with a focus on unlocking the powerful self-renewal properties of the body through specific control of the Wnt signaling pathway. Surrozen was founded by five leading-edge scientists: K. Christopher Garcia, Ph.D, Roel Nusse, Ph.D. and Calvin Kuo, M.D, Ph.D. from Stanford University; Claudia Janda, Ph.D. from the Princess Maxima Center for Pediatric Oncology; and Hans Clevers, M.D, Ph.D. from the Hubrecht Institute and Princess Maxima Center. Each has conducted extensive research on Wnt signaling, with findings that together shape Surrozen’s technology and approach to therapeutic development. The company is backed by The Column Group, a leading biotechnology venture capital firm. We are currently seeking highly creative scientists to join our team, and invite you to explore career opportunities on our website.
11 to 50 staff
Syndel
For over 50 years, Syndel has been in the forefront of developing and marketing approved aquaculture health products worldwide. Syndel has become a global leader in fish health treatments, spawning agents, and biosecurity solutions. We encourage you to contact us for more information on our products, services, and solutions to your aquaculture needs.
51 to 200 staff
